
G.I. Windows
Non-surgical treatment of type-2 diabetes and obesity, by creating endo-luminal anastomoses that bypass portions of the GI tract.
Related Content
GI Windows Surgical is pioneering a groundbreaking anastomotic technology that facilitates less invasive surgical procedures, addressing a significant global need for patients with obesity, Type 2 diabetes, and those undergoing colorectal surgery. The company operates in the medical technology sector, focusing on developing solutions that improve patient outcomes, reduce healthcare costs, and enhance the efficiency of care delivery. GI Windows Surgical's core product leverages magnetic compression anastomosis, which allows for the creation of a wide, permanent anastomosis using a common flexible endoscope in a minimally invasive manner. This innovative approach has the potential to transform digestive surgery practices, offering a simpler and more effective alternative to traditional methods. The company's business model involves the development and commercialization of this technology, targeting healthcare providers and institutions that perform surgical procedures. Revenue is generated through the sale of their proprietary devices and related services. The market for GI Windows Surgical's technology includes hospitals, surgical centers, and clinics that specialize in gastrointestinal and metabolic surgeries. The company is led by a team of experienced professionals with a proven track record in bringing disruptive medical technologies to market.
Keywords: anastomotic technology, less invasive surgery, obesity, Type 2 diabetes, colorectal surgery, magnetic compression, endoscopic procedures, healthcare innovation, surgical devices, patient outcomes.